EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

BRAF mutation predicts survival after immunotherapy across multiple cancer types

Shaojun Zhou, Weiting Ge, Wen Cai

Cancer Treatment and Research Communications · 2026 · 47 · 101215

DOI: 10.1016/j.ctarc.2026.101215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Shaojun Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, The Second People's Hospital of Quzhou, China. Electronic address: zoushaojun2000@163.com. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Neoplasms, Mutation, Immunotherapy. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafNeoplasmsMutationImmunotherapyImmune Checkpoint InhibitorsHumansFemaleMaleMiddle AgedPrognosisAged

Stichwörter der Autor:innen

BRAFImmunotherapyPan-cancer

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Hematology and Oncology, The Second People's Hospital of Quzhou, China. Electronic address: zoushaojun2000@163.com.
  • Center for Basic Research (Key Laboratory of Cancer and Intervention, China National Ministry of Education), the Second Affiliated Hosptital, Zhejiang University School of Medicine, Hangzhou, China; Center for Medical R…
  • Department of Medical Oncology, Zhejiang University School of Medicine, Second Affiliated Hospital, China. Electronic address: caiwen@zju.edu.cn.

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Zhou, S., Ge, W., & Cai, W. (2026). BRAF mutation predicts survival after immunotherapy across multiple cancer types. Cancer Treatment and Research Communications, 47, 101215. https://doi.org/10.1016/j.ctarc.2026.101215

Vancouver

Zhou S, Ge W, Cai W. BRAF mutation predicts survival after immunotherapy across multiple cancer types. Cancer Treatment and Research Communications. 2026;47:101215. doi:10.1016/j.ctarc.2026.101215

BibTeX
@article{Zhou2026,
  author = {Zhou, Shaojun and Ge, Weiting and Cai, Wen},
  title = {BRAF mutation predicts survival after immunotherapy across multiple cancer types},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {47},
  pages = {101215},
  doi = {10.1016/j.ctarc.2026.101215}
}
Kostenlos starten →